Low adiponectin levels and ADIPOQ +276G＞T single nucleotide polymorphism are associated with type 2 diabetes mellitus in the Sudanese population: case-control study

i

This article has been updated. A Correction to this article was published on .

i

The Original Article was published on

i

The Original Article was published on

i

This article has been updated

i

This article was retracted on

i

This article has been updated

Abstract

Aim: Type 2 diabetes mellitus is a polygenic disorder influenced by multiple genes and environmental factors. Polymorphisms in the adiponectin gene are linked to insulin resistance, serum adiponectin levels, and type 2 diabetes mellitus. This study investigated the association between adiponectin levels, the ADIPOQ +276G>T single nucleotide polymorphism (SNP), and type 2 diabetes in the Sudanese population. Methods: A case-control study involved 202 individuals with type 2 diabetes and 100 controls, after providing written informed consent. Blood samples were collected after overnight fasting for measurements of fasting blood glucose (FBG), and hemoglobin A1C (HbA1c) levels were measured using enzymatic methods. Participants’ body mass index (BMI) was calculated based on weight and height measurements. Adiponectin levels were measured by sandwich ELISA. Adiponectin gene +276G>T SNP was performed using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Results: Patients with type 2 diabetes had significantly lower adiponectin levels compared to controls (P < 0.001). The distribution of the +276G>T SNP genotypes and the T allele was significantly different between diabetic patients and controls, with TT, GT, and T allele more frequent in diabetics (P < 0.05). Adiponectin levels varied by genotype, with GG carriers having higher levels than GT and TT carriers, who exhibited significantly lower levels (P < 0.001). Conclusions: The +276G>T SNP in the adiponectin gene is associated with reduced adiponectin levels in individuals with type 2 diabetes in the Sudanese population.

Keywords

type 2 diabetes mellitus / adiponectin / single nucleotide polymorphism

CHANGE HISTORY

A Correction to this paper has been published:
https://doi.org

The Retraction Note was updated to reflect reception of statements of disagreement from all authors.

This article has been retracted.Please see the Retraction Notice for more detail:
https://doi.org

References

[1] Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2017; 14: 88-98.

[2] Lin X, Xu Y, Pan X, Xu J, Ding Y, Sun X, et al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep. 2020; 10: 14790.

[3] Tomic D, Shaw JE, Magliano DJ. The burden and risks of emerging complications of diabetes mellitus. Nat Rev Endocrinol. 2022; 18: 525-39.

[4] Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018; 138: 271-81.

[5] Kalyani RR, Neumiller JJ, Maruthur NM, Wexler DJ. Diagnosis and Treatment of Type 2 Diabetes in Adults. JAMA. 2025; 334: 984-1002.

[6] Yun JS, Jung SH, Shivakumar M, Xiao B, Khera AV, Won HH, et al. Polygenic risk for type 2 diabetes, lifestyle, metabolic health, and cardiovascular disease: a prospective UK Biobank study. Cardiovasc Diabetol. 2022; 21: 131.

[7] Mannar V, Boro H, Patel D, Agstam S, Dalvi M, Bundela V. Epigenetics of the Pathogenesis and Complications of Type 2 Diabetes Mellitus. Eur Endocrinol. 2023; 19: 46-53.

[8] Bazzazzadehgan S, Shariat-Madar Z, Mahdi F. Distinct Roles of Common Genetic Variants and Their Contributions to Diabetes: MODY and Uncontrolled T2DM. Biomolecules. 2025; 15: 414.

[9] Cui M, Gao Y, Zhao Y, Pang H, Chen L, Wang Z, et al. Association between Adiponectin Gene Polymorphism and Environmental Risk Factors of Type 2 Diabetes Mellitus among the Chinese Population in Hohhot. BioMed Res Int. 2020; 2020: 6383906.

[10] Wheeler E, Barroso I. Genome-wide association studies and type 2 diabetes. Brief Funct Genom. 2011; 10: 52-60.

[11] Mahajan A, Taliun D, Thurner M, Robertson NR, Torres JM, Rayner NW, et al. Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. Nat Genet. 2018; 50: 1505-13.

[12] Howlader M, Sultana MI, Akter F, Hossain MM. Adiponectin gene polymorphisms associated with diabetes mellitus: A descriptive review. Heliyon. 2021; 7: e07851.

[13] Begum M, Choubey M, Tirumalasetty MB, Arbee S, Mohib MM, Wahiduzzaman M, et al. Adiponectin: A Promising Target for the Treatment of Diabetes and Its Complications. Life. 2023; 13: 2213.

[14] Khoramipour K, Chamari K, Hekmatikar AA, Ziyaiyan A, Taherkhani S, Elguindy NM, et al. Adiponectin: Structure, Physiological Functions, Role in Diseases, and Effects of Nutrition. Nutrients. 2021; 13: 1180.

[15] Tao C, Sifuentes A, Holland WL. Regulation of glucose and lipid homeostasis by adiponectin: Effects on hepatocytes, pancreatic β cells and adipocytes. Best Pract Res Clin Endocrinol Metab. 2014; 28: 43-58.

[16] Alimi M, Goodarzi MT, Nekoei M. Association of ADIPOQ rs266729 and rs1501299 gene polymorphisms and circulating adiponectin level with the risk of type 2 diabetes in a population of Iran: a case-control study. J Diabetes Metab Disord. 2021; 20: 87-93.

[17] Guo Z, Xia Z, Yuen VG, McNeill JH. Cardiac expression of adiponectin and its receptors in streptozotocin-induced diabetic rats. Metabolism. 2007; 56: 1363-71.

[18] El-Shal AS, Zidan HE, Rashad NM. Adiponectin gene polymorphisms in Egyptian type 2 diabetes mellitus patients with and without diabetic nephropathy. Mol Biol Rep. 2014; 41: 2287-98.

[19] Amrita J, Mahajan M, Bhanwer AJS, Matharoo K. Association of AdipoQ gene variation (rs1501299) and oxidative stress with cardiovascular disease in North West Indian population of Punjabi women. J Med Biochem. 2021; 40: 49-59.

[20] Han LY, Wu QH, Jiao ML, Hao YH, Liang LB, Gao LJ, et al. Associations between single-nucleotide polymorphisms (+45T>G, +276G>T, −11377C>G, −11391G>A) of adiponectin gene and type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetologia. 2011; 54: 2303-14.

[21] American Diabetes Association Professional Practice Committee for Diabetes. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2026. Diabetes Care. 2026; 49: S27-49.

[22] Arifin WN. Introduction to sample size calculation. Educ Med J. 2013; 5: 89-96.

[23] Karami A, Baradaran A. Comparative evaluation of three different methods for HbA1c measurement with High-performance liquid chromatography in diabetic patients. Adv Biomed Res. 2014; 3: 94.

[24] Rutkowski JM, Scherer PE. Isolation and Quantitation of Adiponectin Higher Order Complexes. Methods Enzymol. 2014; 537: 243-59.

[25] Ghatak S, Muthukumaran RB, Nachimuthu SK. A Simple Method of Genomic DNA Extraction from Human Samples for PCR-RFLP Analysis. J Biomol Tech. 2013; 24: 224-31.

[26] Momin AA, Bankar MP, Bhoite GM. Association of Single Nucleotide Polymorphisms of Adiponectin Gene with Type 2 Diabetes Mellitus, and Their Influence on Cardiovascular Risk Markers. Indian J Clin Biochem. 2016; 32: 53-60.

[27] Ji ZY, Li HF, Lei Y, Rao YW, Tan ZX, Liu HJ, et al. Association of adiponectin gene polymorphisms with an elevated risk of diabetic peripheral neuropathy in type 2 diabetes patients. J Diabetes Complicat. 2015; 29: 887-92.

[28] Mohammadzadeh G, Zarghami N. Associations between single-nucleotide polymorphisms of the adiponectin gene, serum adiponectin levels and increased risk of type 2 diabetes mellitus in Iranian obese individuals. Scand J Clin Lab Invest. 2009; 69: 764-71.

[29] Hong X, Zhang X, You L, Li F, Lian H, Wang J, et al. Association between adiponectin and newly diagnosed type 2 diabetes in population with the clustering of obesity, dyslipidaemia and hypertension: a cross-sectional study. BMJ Open. 2023; 13: e060377.

[30] Abudalo R, Alqudah A, Qnais E, Athamneh RY, Oqal M, Alnajjar R. Interplay of adiponectin and resistin in type 2 diabetes: Implications for insulin resistance and atherosclerosis. Pharmacia. 2024; 71: 1-8.

[31] Frankenberg ADV, Reis AF, Gerchman F. Relationships between adiponectin levels, the metabolic syndrome, and type 2 diabetes: a literature review. Arch Endocrinol Metab. 2017; 61: 614-22.

[32] Karbowska J, Kochan Z. Role of adiponectin in the regulation of carbohydrate and lipid metabolism. J Physiol Pharmacol. 2006; 57: 103-13.

[33] Awazawa M, Ueki K, Inabe K, Yamauchi T, Kubota N, Kaneko K, et al. Adiponectin Enhances Insulin Sensitivity by Increasing Hepatic IRS-2 Expression via a Macrophage-Derived IL-6-Dependent Pathway. Cell Metab. 2011; 13: 401-12.

[34] Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab. 2002; 13: 84-9.

[35] Yang WS, Yang YC, Chen CL, Wu IL, Lu JY, Lu FH, et al. Adiponectin SNP276 is associated with obesity, the metabolic syndrome, and diabetes in the elderly. Am J Clin Nutr. 2007; 86: 509-13.

[36] Ramya K, Ayyappa KA, Ghosh S, Mohan V, Radha V. Genetic association of ADIPOQ gene variants with type 2 diabetes, obesity and serum adiponectin levels in south Indian population. Gene. 2013; 532: 253-62.

[37] Hara K, Boutin P, Mori Y, Tobe K, Dina C, Yasuda K, et al. Genetic Variation in the Gene Encoding Adiponectin Is Associated With an Increased Risk of Type 2 Diabetes in the Japanese Population. Diabetes. 2002; 51: 536-40.

[38] Farooq R, Majid S, Ahmad Bhat SA, Amin S, Hayat Bhat M, Ahmad Wani H, et al. Association of adiponectin gene polymorphism with type 2 diabetes and metabolic syndrome. Transl Metab Syndr Res. 2018; 1: 39-47.

[39] Zacharova J, Chiasson JL, Laakso M ; STOP-NIDDM Study Group. The Common Polymorphisms (Single Nucleotide Polymorphism [SNP] +45 and SNP +276) of the Adiponectin Gene Predict the Conversion From Impaired Glucose Tolerance to Type 2 Diabetes. Diabetes. 2005; 54: 893-9.

[40] Abd-Elbaky AE, M Abo-El Matty D. Adiponectin (+276 G/T), Tumor Necrosis Factor-alpha (-308 G/A) and Interleukin-6 (-174 C/G) Genes Polymorphisms in Egyptian Type 2 Diabetic Patients. J Diabetes Metab. 2016; 07: e07.